treatment protocol for hypothyroidism in dogs
| Parameter | Detail |
|---|---|
| Starting dose | 0.02 mg/kg (20 µg/kg) PO q12h |
| Maximum starting dose | 0.8 mg per dose (regardless of body weight) |
| Frequency | Twice daily (BID) preferred initially; some dogs can be maintained on once daily (SID) after stabilization |
| Formulation | Canine-specific tablets preferred; human formulations have variable bioavailability in dogs |
Large/giant breeds often need relatively lower doses (mg/kg basis). Start conservatively and titrate.
| Target | Value |
|---|---|
| Post-pill TT4 | Upper half of reference range or slightly above (2.5–4.5 µg/dL typical) |
| TSH | Should normalize (< 0.5 ng/mL) within 4–8 weeks |
| Sign | Expected Resolution |
|---|---|
| Lethargy, mental dullness | 1–2 weeks |
| Weight loss | 4–8 weeks |
| Coat/skin improvement | 2–3 months |
| Neurological signs (if present) | 1–3 months |
| Reproductive abnormalities | 2–3 months |